Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Eiger BioPharmaceuticals, Inc. | Director | Stock Option (Right to Buy) | 40K | Mar 1, 2023 | Direct | ||
LEAP THERAPEUTICS, INC. | Director | Stock Option (Right to Buy) | 30K | Oct 2, 2024 | Direct | ||
Paratek Pharmaceuticals, Inc. | Director | Common Stock | 0 | $2.20 | Sep 21, 2023 | Direct | |
Paratek Pharmaceuticals, Inc. | Director | Stock option (right to buy) | 0 | Sep 21, 2023 | Direct |